G
Genoox
Biotech & Life Sciences · Palo Alto, United States · Founded 2014
A healthcare and technology company on a mission to make clinical genetic sequencing more accessible MoreLess
Genoox operates in the genomic data analysis market, providing a cloud-based platform that translates complex genetic data into clinical results. The platform is designed to manage the sequencing process from raw genetic data to actionable insights, making it a valuable tool for healthcare professionals and researchers. Genoox serves clients such as hospitals, research institutions, and clinical laboratories, offering them an efficient workflow for data analysis. The business model is subscription-based, with clients paying for access to the platform's premium features, including unlimited sample analysis, storage, and various data processing tools. Genoox generates revenue through these subscriptions and offers a 14-day free trial to attract new users. The platform's key features include multiple variant calling and validation tools, an annotation engine, and automated genotypic and phenotypic correlation. Genoox also provides professional services and support to ensure clients can maximize the platform's capabilities.
Keywords: genomic data, cloud-based platform, NGS analysis, clinical insights, healthcare, research institutions, subscription model, data processing, variant calling, annotation engine.
Company overview
Genoox company information
The essential company record, classifications and operating signals in one place.
- Status
- Acquired
- Founded
- 2014
- Headquarters
- Palo Alto, United States
- Employees
- 53
- Open positions
- None listed
- Dealroom signal
- 64.6
Valuation & funding
Genoox funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITION✓Exit | May 2025 | $70M | $70M | Qiagen | ↗ |
| SERIES C✓Equity / VC | Aug 2023 | $12M | $48M | Undisclosed | — |
| SERIES B✓Equity / VC | Feb 2021 | $8M | $32M | Inimiti · Infinity Medical · TriVentures · Glilot Capital Partners | — |
| EARLY VC✓Equity / VC | May 2018 | $6M | $24M | Inimiti · TriVentures · Glilot Capital Partners | ↗ |
| SERIES A✓Equity / VC | Jul 2017 | $6M | $24M | Glilot Capital Partners · Inimiti | ↗ |
| GRANT✓Other financing | Nov 2016 | MassChallenge | — | ||
| GRANT✓Other financing | Mar 2016 | Microsoft for Startups | — | ||
| SUPPORT PROGRAM✓Other financing | Dec 2014 | Google for Startups Accelerator | — | ||
| SEED✓Equity / VC | Aug 2014 | UpWest Labs | — |
Financials
Revenue and workforce over time
Available revenue and workforce history. Fields without reported data are omitted.
| Year | Revenue | Growth | Employees |
|---|---|---|---|
| 2026 | $3.9M | 0% | 51 |
| 2025 | $3.9M | 0% | 54 |
| 2024 | $3.9M | 0% | 51 |
| 2023 | $3.9M | +14.7% | 44 |
| 2022 | $3.4M | +3% | 37 |
| 2021 | $3.3M | +10% | 33 |
| 2020 | $3M | — | 24 |
Growth signals
Genoox website traffic
Latest recorded traffic for Genoox is 110K monthly website visits, up 0% over the last three months. Genoox's team declined 1.9% over the past year.
Comparisons
Genoox compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Genoox's talent
Source: Dealroom Talent Intelligence.
Investors
12 investors on Genoox's cap table
Sourced from Dealroom's funding and investor records.
Global footprint
Where Genoox has talent and traffic
team presence
In the news
Latest news about Genoox
Recent press, funding announcements, and product moves mentioning Genoox — open to read from the original sources.
Market sentiment
What the market is saying about Genoox
An AI-synthesized read of the highest-engagement posts about Genoox on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Genoox’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.